{
    "id": 38,
    "premise": "none",
    "hypothesis": "CFI-402257 may be suitable for this patient.",
    "label": "entailment",
    "explanation": "A TTK Inhibitor may be effective in this patient.\nCFI-402257 Is a TTK inhibitor in phase 1 studies in patients with Breast cancer and advanced solid tumours.",
    "results": {
        "semantic validity": true,
        "premise": null,
        "hypothesis": "CFI-402257 may be suitable for this patient.",
        "refined explanation": "CFI-402257 is a TTK inhibitor in phase 1 studies in patients with Breast cancer and advanced solid tumours.\nA TTK Inhibitor may be effective in this patient, and CFI-402257 is a TTK inhibitor.\nIf CFI-402257, as a TTK Inhibitor, is effective in a patient, then it may be suitable for that patient.",
        "refined iteration": 3,
        "history explanation": [
            "0 iteration: A TTK Inhibitor may be effective in this patient.\nCFI-402257 Is a TTK inhibitor in phase 1 studies in patients with Breast cancer and advanced solid tumours.",
            "1 iteration: A TTK Inhibitor may be effective in this patient.\nCFI-402257 is a TTK inhibitor in phase 1 studies in patients with Breast cancer and advanced solid tumours.\nIf a TTK Inhibitor is effective in a patient, then it may be suitable for that patient.",
            "2 iteration: A TTK Inhibitor may be effective in this patient.\nCFI-402257 is a TTK inhibitor in phase 1 studies in patients with Breast cancer and advanced solid tumours.\nIf CFI-402257, as a TTK Inhibitor, is effective in a patient, then it may be suitable for that patient.",
            "3 iteration: CFI-402257 is a TTK inhibitor in phase 1 studies in patients with Breast cancer and advanced solid tumours.\nA TTK Inhibitor may be effective in this patient, and CFI-402257 is a TTK inhibitor.\nIf CFI-402257, as a TTK Inhibitor, is effective in a patient, then it may be suitable for that patient."
        ],
        "history semantic validity": [
            "0 iteration: False",
            "1 iteration: False",
            "2 iteration: False",
            "3 iteration: True"
        ],
        "history critique output": [
            "0 iteration: {'syntactic validity': True, 'error code': '(* Explanation 1 states that a TTK Inhibitor may be effective in this patient. *)\\n(* Explanation 2 states that CFI-402257 is a TTK inhibitor. *)\\n(* Therefore, we can infer that CFI-402257 may be effective in this patient. *)\\n(* If CFI-402257 is effective, it may be suitable for the patient. *)\\nthen have \"SuitableFor x y\" sledgehammer', 'solving time': 104.68519449234009, 'proof tactics': [], 'code': 'theory clinical_38_0\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  TTKInhibitor :: \"entity \u21d2 bool\"\\n  Patient :: \"entity \u21d2 bool\"\\n  EffectiveIn :: \"entity \u21d2 entity \u21d2 bool\"\\n  CFI402257 :: \"entity \u21d2 bool\"\\n  Phase1Studies :: \"entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  BreastCancer :: \"entity \u21d2 bool\"\\n  AdvancedSolidTumours :: \"entity \u21d2 bool\"\\n  Patients :: \"entity \u21d2 bool\"\\n  SuitableFor :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: A TTK Inhibitor may be effective in this patient. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y. TTKInhibitor x \u2227 Patient y \u2227 EffectiveIn x y\"\\n\\n(* Explanation 2: CFI-402257 is a TTK inhibitor in phase 1 studies in patients with Breast cancer and advanced solid tumours. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z. CFI402257 x \u2227 TTKInhibitor x \u2227 Phase1Studies y \u2227 In x y \u2227 Patients z \u2227 BreastCancer z \u2227 AdvancedSolidTumours z \u2227 In z y\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"CFI402257 x \u2227 Patient y\"\\n  (* Hypothesis: CFI-402257 may be suitable for this patient. *)\\n  shows \"\u2203x y. CFI402257 x \u2227 Patient y \u2227 SuitableFor x y\"\\nproof -\\n  (* From the premise, we have known information about CFI-402257 and the patient. *)\\n  from asm have \"CFI402257 x \u2227 Patient y\" <ATP>\\n  (* Explanation 1 states that a TTK Inhibitor may be effective in this patient. *)\\n  (* Explanation 2 states that CFI-402257 is a TTK inhibitor. *)\\n  (* Therefore, we can infer that CFI-402257 may be effective in this patient. *)\\n  (* If CFI-402257 is effective, it may be suitable for the patient. *)\\n  then have \"SuitableFor x y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: TTK Inhibitor may be effective in this patient (from Explanatory Sentence 1)\\nB: CFI-402257 is a TTK inhibitor (from Explanatory Sentence 2)\\nC: CFI-402257 is in phase 1 studies in patients with Breast cancer and advanced solid tumours (from Explanatory Sentence 2)\\n\\nLogical Relations:\\n\\nDerived Implications:\\n'}",
            "1 iteration: {'syntactic validity': True, 'error code': '(* Since CFI-402257 is a TTK inhibitor and may be effective in the patient, it follows that it may be suitable for the patient. *)\\nthen have \"SuitableFor x y\" sledgehammer', 'solving time': 151.08480525016785, 'proof tactics': [], 'code': 'theory clinical_38_1\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  TTKInhibitor :: \"entity \u21d2 bool\"\\n  Patient :: \"entity \u21d2 bool\"\\n  EffectiveIn :: \"entity \u21d2 entity \u21d2 bool\"\\n  CFI402257 :: \"entity \u21d2 bool\"\\n  Phase1Studies :: \"entity \u21d2 bool\"\\n  BreastCancer :: \"entity \u21d2 bool\"\\n  AdvancedSolidTumours :: \"entity \u21d2 bool\"\\n  InStudies :: \"entity \u21d2 entity \u21d2 bool\"\\n  InPatients :: \"entity \u21d2 entity \u21d2 bool\"\\n  SuitableFor :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: A TTK Inhibitor may be effective in this patient. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y. TTKInhibitor x \u2227 Patient y \u2227 EffectiveIn x y\"\\n\\n(* Explanation 2: CFI-402257 is a TTK inhibitor in phase 1 studies in patients with Breast cancer and advanced solid tumours. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z. CFI402257 x \u2227 TTKInhibitor x \u2227 Phase1Studies y \u2227 Patient z \u2227 BreastCancer z \u2227 AdvancedSolidTumours z \u2227 InStudies x y \u2227 InPatients y z\"\\n\\n(* Explanation 3: If a TTK Inhibitor is effective in a patient, then it may be suitable for that patient. *)\\naxiomatization where\\n  explanation_3: \"\u2200x y. (TTKInhibitor x \u2227 Patient y \u2227 EffectiveIn x y) \u27f6 SuitableFor x y\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"CFI402257 x \u2227 Patient y\"\\n  (* Hypothesis: CFI-402257 may be suitable for this patient. *)\\n  shows \"\u2203x y. CFI402257 x \u2227 Patient y \u2227 SuitableFor x y\"\\nproof -\\n  (* From the premise, we have known information about CFI-402257 and the patient. *)\\n  from asm have \"CFI402257 x \u2227 Patient y\" <ATP>\\n  (* Explanation 1 states that a TTK Inhibitor may be effective in this patient. *)\\n  from explanation_1 obtain a b where \"TTKInhibitor a \u2227 Patient b \u2227 EffectiveIn a b\" <ATP>\\n  (* Explanation 2 states that CFI-402257 is a TTK inhibitor. *)\\n  from explanation_2 obtain c where \"CFI402257 c \u2227 TTKInhibitor c\" <ATP>\\n  (* Explanation 3 provides a logical relation: If a TTK Inhibitor is effective in a patient, then it may be suitable for that patient. *)\\n  from explanation_3 have \"\u2200x y. (TTKInhibitor x \u2227 Patient y \u2227 EffectiveIn x y) \u27f6 SuitableFor x y\" <ATP>\\n  (* Since CFI-402257 is a TTK inhibitor and may be effective in the patient, it follows that it may be suitable for the patient. *)\\n  then have \"SuitableFor x y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: TTK Inhibitor may be effective in this patient (from Explanatory Sentence 1)\\nB: CFI-402257 is a TTK inhibitor (from Explanatory Sentence 2)\\nC: CFI-402257 is in phase 1 studies in patients with Breast cancer and advanced solid tumours (from Explanatory Sentence 2)\\nD: TTK Inhibitor is effective in a patient (from Explanatory Sentence 3)\\nE: TTK Inhibitor may be suitable for that patient (from Explanatory Sentence 3)\\n\\nLogical Relations:\\nImplies(D, E)\\nImplies(TTK Inhibitor is effective in a patient, TTK Inhibitor may be suitable for that patient)\\n--------\\n\\nDerived Implications:\\n'}",
            "2 iteration: {'syntactic validity': True, 'error code': '(* Since CFI-402257 is a TTK Inhibitor, we can substitute a with x and b with y. *)\\nthen have \"EffectiveIn x y\" sledgehammer', 'solving time': 119.42364740371704, 'proof tactics': [], 'code': 'theory clinical_38_2\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  TTKInhibitor :: \"entity \u21d2 bool\"\\n  Patient :: \"entity \u21d2 bool\"\\n  EffectiveIn :: \"entity \u21d2 entity \u21d2 bool\"\\n  CFI402257 :: \"entity \u21d2 bool\"\\n  Phase1Studies :: \"entity \u21d2 bool\"\\n  BreastCancer :: \"entity \u21d2 bool\"\\n  AdvancedSolidTumours :: \"entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  SuitableFor :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: A TTK Inhibitor may be effective in this patient. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y. TTKInhibitor x \u2227 Patient y \u2227 EffectiveIn x y\"\\n\\n(* Explanation 2: CFI-402257 is a TTK inhibitor in phase 1 studies in patients with Breast cancer and advanced solid tumours. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z. CFI402257 x \u2227 TTKInhibitor x \u2227 Phase1Studies y \u2227 Patient z \u2227 BreastCancer z \u2227 AdvancedSolidTumours z \u2227 In x y \u2227 In x z\"\\n\\n(* Explanation 3: If CFI-402257, as a TTK Inhibitor, is effective in a patient, then it may be suitable for that patient. *)\\naxiomatization where\\n  explanation_3: \"\u2200x y. (CFI402257 x \u2227 TTKInhibitor x \u2227 Patient y \u2227 EffectiveIn x y) \u27f6 SuitableFor x y\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"CFI402257 x \u2227 Patient y\"\\n  (* Hypothesis: CFI-402257 may be suitable for this patient *)\\n  shows \"\u2203x y. CFI402257 x \u2227 Patient y \u2227 SuitableFor x y\"\\nproof -\\n  (* From the premise, we have known information about CFI-402257 and the patient. *)\\n  from asm have \"CFI402257 x \u2227 Patient y\" <ATP>\\n  (* Explanation 1 states that a TTK Inhibitor may be effective in this patient. *)\\n  (* Explanation 2 confirms that CFI-402257 is a TTK inhibitor. *)\\n  (* Explanation 3 provides a logical relation: If CFI-402257, as a TTK Inhibitor, is effective in a patient, then it may be suitable for that patient. *)\\n  (* We need to show that CFI-402257 is effective in the patient to use the logical relation from Explanation 3. *)\\n  (* Explanation 1 implies that there exists a TTK Inhibitor effective in a patient, which can be CFI-402257. *)\\n  from explanation_1 obtain a b where \"TTKInhibitor a \u2227 Patient b \u2227 EffectiveIn a b\" <ATP>\\n  (* Since CFI-402257 is a TTK Inhibitor, we can substitute a with x and b with y. *)\\n  then have \"EffectiveIn x y\" <ATP>\\n  (* Now, using Explanation 3, we can infer that CFI-402257 may be suitable for the patient. *)\\n  then have \"SuitableFor x y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: TTK Inhibitor may be effective in this patient (from Explanatory Sentence 1)\\nB: CFI-402257 is a TTK inhibitor (from Explanatory Sentence 2)\\nC: CFI-402257 is in phase 1 studies in patients with Breast cancer and advanced solid tumours (from Explanatory Sentence 2)\\nD: CFI-402257 is effective in a patient (from Explanatory Sentence 3)\\nE: CFI-402257 may be suitable for that patient (from Explanatory Sentence 3)\\n\\nLogical Relations:\\nImplies(D, E)\\nImplies(CFI-402257 is effective in a patient, CFI-402257 may be suitable for that patient)\\n--------\\n\\nDerived Implications:\\n'}",
            "3 iteration: {'syntactic validity': True, 'error code': '', 'solving time': 11.019307374954224, 'proof tactics': ['Sledgehammering...', 'zipperposition found a proof...', 'cvc4 found a proof...', 'e found a proof...', 'vampire found a proof...', 'cvc4 found a proof...', 'zipperposition: Try this: using explanation_2 explanation_3 by blast (13 ms)', 'e: Try this: by (meson explanation_2 explanation_3) (12 ms)', 'cvc4: Try this: by (metis explanation_2 explanation_3) (32 ms)', 'zipperposition found a proof...', 'cvc4: Found duplicate proof', 'vampire: Found duplicate proof', 'zipperposition: Found duplicate proof', 'Done'], 'code': 'theory clinical_38_3\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  CFI402257 :: \"entity \u21d2 bool\"\\n  TTKInhibitor :: \"entity \u21d2 bool\"\\n  Phase1Studies :: \"entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  Patient :: \"entity \u21d2 bool\"\\n  BreastCancer :: \"entity \u21d2 bool\"\\n  AdvancedSolidTumours :: \"entity \u21d2 bool\"\\n  EffectiveIn :: \"entity \u21d2 entity \u21d2 bool\"\\n  SuitableFor :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: CFI-402257 is a TTK inhibitor in phase 1 studies in patients with Breast cancer and advanced solid tumours. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z. CFI402257 x \u2227 TTKInhibitor x \u2227 Phase1Studies y \u2227 In x y \u2227 Patient z \u2227 BreastCancer z \u2227 AdvancedSolidTumours z \u2227 In z y\"\\n\\n(* Explanation 2: A TTK Inhibitor may be effective in this patient, and CFI-402257 is a TTK inhibitor. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y. TTKInhibitor x \u2227 Patient y \u2227 EffectiveIn x y \u2227 CFI402257 z \u2227 TTKInhibitor z\"\\n\\n(* Explanation 3: If CFI-402257, as a TTK Inhibitor, is effective in a patient, then it may be suitable for that patient. *)\\naxiomatization where\\n  explanation_3: \"\u2200x y. (CFI402257 x \u2227 TTKInhibitor x \u2227 Patient y \u2227 EffectiveIn x y) \u27f6 SuitableFor x y\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"CFI402257 x \u2227 Patient y\"\\n  (* Hypothesis: CFI-402257 may be suitable for this patient *)\\n  shows \"\u2203x y. CFI402257 x \u2227 Patient y \u2227 SuitableFor x y\"\\nproof -\\n  (* From the premise, we have known information about CFI-402257 and the patient. *)\\n  from asm have \"CFI402257 x \u2227 Patient y\" <ATP>\\n  (* Explanation 2 provides that CFI-402257 is a TTK inhibitor and may be effective in this patient. *)\\n  (* There is a logical relation Implies(A, C), Implies(CFI-402257 is a TTK inhibitor, A TTK inhibitor may be effective in this patient) *)\\n  (* From explanation_2, we can infer that CFI-402257 may be effective in this patient. *)\\n  then have \"EffectiveIn x y\" <ATP>\\n  (* Explanation 3 provides that if CFI-402257 is effective in a patient, then it may be suitable for that patient. *)\\n  (* There is a logical relation Implies(D, E), Implies(CFI-402257 may be effective in a patient, CFI-402257 may be suitable for that patient) *)\\n  (* We can use this to infer that CFI-402257 may be suitable for this patient. *)\\n  then have \"SuitableFor x y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: CFI-402257 is a TTK inhibitor (from Explanatory Sentence 1 and 2)\\nB: CFI-402257 is in phase 1 studies in patients with Breast cancer and advanced solid tumours (from Explanatory Sentence 1)\\nC: A TTK inhibitor may be effective in this patient (from Explanatory Sentence 2)\\nD: CFI-402257 may be effective in a patient (from Explanatory Sentence 3)\\nE: CFI-402257 may be suitable for that patient (from Explanatory Sentence 3)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(CFI-402257 is a TTK inhibitor, CFI-402257 is in phase 1 studies in patients with Breast cancer and advanced solid tumours)\\n--------\\nImplies(A, C)\\nImplies(CFI-402257 is a TTK inhibitor, A TTK inhibitor may be effective in this patient)\\n--------\\nImplies(D, E)\\nImplies(CFI-402257 may be effective in a patient, CFI-402257 may be suitable for that patient)\\n--------\\n\\nDerived Implications:\\n'}"
        ]
    }
}